IRIDIAN ASSET MANAGEMENT LLC/CT
Position in BCTX — BriaCell Therapeutics Corp.
CIK 1033427
WESTPORT, CT
Position in BCTX
as of Mar 31, 2026
· filed Apr 24, 2026
Position Value
$272,350
New position
Shares Held
65,000
first reported quarter
Ownership
0.747%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Mar 31, 2026IRIDIAN ASSET MANAGEMENT LLC/CT holds $35,697,443 across 7 Biotechnology names. BCTX ranks #7 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PGEN |
Precigen, Inc.
|
3,592,730 | $13,903,865 | |
| 2 | AXSM |
Axsome Therapeutics, Inc.
|
67,491 | $11,407,328 | |
| 3 | NVCT |
Nuvectis Pharma, Inc.
|
651,757 | $5,038,081 | |
| 4 | TGTX |
Tg Therapeutics, Inc.
|
75,289 | $2,501,100 | |
| 5 | NKTR |
Nektar Therapeutics
|
31,320 | $2,253,474 | |
| 6 | ELTX |
Elicio Therapeutics, Inc.
|
30,051 | $321,245 | |
| 7 | BCTX |
BriaCell Therapeutics Corp.
This page
|
65,000 | $272,350 |
All Filings in BCTX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $272,350 | 65,000 | Shares | Sole | 2026-04-24 | |
| No filing history on record for this holder in this stock. | ||||||